{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:03:04Z","timestamp":1789390984542,"version":"build-2803163510"},"reference-count":41,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Neuroblastoma is among the most aggressive pediatric cancers, and resistance to standard therapies highlights the need for alternative strategies targeting lipid metabolism and apoptosis-associated pathways. This study aimed to investigate the cytotoxic and apoptotic effects of fingolimod, ceranib-2, and carmofur, administered individually and in combination, in SH-SY5Y neuroblastoma cells, with particular emphasis on ceramide metabolism. Cytotoxicity was evaluated using the MTT assay, and morphological alterations were assessed by confocal microscopy. Colony-forming ability was examined using a soft agar assay, apoptosis-associated responses were evaluated by Annexin-V staining and caspase 3\/7 activation analysis, and intracellular ceramide levels were determined using an ELISA-based method. The results showed that all three compounds reduced cell viability in a concentration-dependent manner and decreased clonogenic survival. The triple combination produced the most pronounced changes in apoptosis-associated parameters and showed marked inhibition of colony formation, although fingolimod alone exhibited the lowest IC50 value and therefore remained the most potent treatment on an IC50 basis. Confocal microscopy revealed prominent apoptosis-associated morphological alterations, including chromatin condensation, nuclear fragmentation, and cytoskeletal disruption, particularly in the triple-combination group. Annexin-V and caspase 3\/7 analyses showed increased apoptotic cell populations, with the highest levels observed following triple-combination treatment. Intracellular ceramide levels were also significantly elevated, particularly in cells treated with ceranib-2 and the triple combination. Collectively, these findings indicate that simultaneous modulation of ceramide- and S1P-associated pathways influences apoptosis-associated responses, clonogenic growth, and intracellular ceramide levels in SH-SY5Y cells. However, because the study was conducted in a single neuroblastoma cell line and did not include comprehensive dose-by-time or formal combination-interaction analyses, the findings should be regarded as preliminary in vitro observations. Further validation in genetically distinct neuroblastoma models, together with systematic dose\u2013response and time\u2013response studies, will be required to determine the reproducibility, biological significance, and broader therapeutic relevance of this approach.<\/jats:p>","DOI":"10.3390\/ijms27188126","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:09:51Z","timestamp":1789387791000},"page":"8126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined Modulation of Ceramide and S1P Pathways Induces Strong Cytotoxicity in SH-SY5Y Neuroblastoma Cells"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3618-6033","authenticated-orcid":false,"given":"Celal Ozbek","family":"Cakir","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Afyon Park Hayat Hospital, Afyon 03100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan Vejselova","family":"Sezer","sequence":"additional","affiliation":[{"name":"Department of Biology, Kutahya Dumlupinar University, K\u00fctahya 43000, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-8371","authenticated-orcid":false,"given":"Mustafa","family":"Cengiz","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Physical Sciences Education, Siirt University, Siirt 56100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Mehtap","family":"Kutlu","sequence":"additional","affiliation":[{"name":"Department of Biology, Eskisehir Technical University, Eskisehir 26470, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kafoud, A., Salahuddin, Z., Ibrahim, R.S., Al-Janahi, R., Mazurakova, A., Kubatka, P., and B\u00fcsselberg, D. (2023). Potential treatment options for neuroblastoma with polyphenols through anti-proliferative and apoptotic mechanisms. Biomolecules, 13.","DOI":"10.3390\/biom13030563"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/cts.13593","article-title":"Investigation of the anticancer mechanism of monensin via apoptosis-related factors in SH-SY5Y neuroblastoma cells","volume":"16","author":"Oy","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhou, X., Wang, X., Li, N., Guo, Y., Yang, X., and Lei, Y. (2023). Therapy resistance in neuroblastoma: Mechanisms and reversal strategies. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1114295"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","article-title":"The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: Focus on organic pollutants","volume":"92","author":"Coumoul","year":"2022","journal-title":"Neurotoxicology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"170033","DOI":"10.1038\/sdata.2017.33","article-title":"Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines","volume":"4","author":"Harenza","year":"2017","journal-title":"Sci. Data"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Mercatelli, D., Balboni, N., Palma, A., Aleo, E., Sanna, P.P., Perini, G., and Giorgi, F.M. (2021). Single-cell gene network analysis and transcriptional landscape of MYCN-amplified neuroblastoma cell lines. Biomolecules, 11.","DOI":"10.3390\/biom11020177"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"a014415","DOI":"10.1101\/cshperspect.a014415","article-title":"Neuroblastoma and MYCN","volume":"3","author":"Huang","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e70033","DOI":"10.1111\/bpa.70033","article-title":"The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system","volume":"36","author":"Li","year":"2026","journal-title":"Brain Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhao, L., Spassieva, S.D., Jucius, T.J., Shultz, L.D., Shick, H.E., Macklin, W.B., Hannun, Y.A., Obeid, L.M., and Ackerman, S.L. (2011). A deficiency of ceramide biosynthesis causes cerebellar Purkinje cell neurodegeneration and lipofuscin accumulation. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002063"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas","volume":"284","author":"Imgrund","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1194\/jlr.S092874","article-title":"Advances in determining signaling mechanisms of ceramide and role in disease","volume":"60","author":"Stith","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nchembio.1059","article-title":"Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"8","author":"Sentelle","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1038\/s41467-023-42595-7","article-title":"CerS6-dependent ceramide synthesis in hypothalamic neurons promotes ER\/mitochondrial stress and impairs glucose homeostasis in obese mice","volume":"14","author":"Hammerschmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4103\/NRR.NRR-D-23-01933","article-title":"Inhibiting ceramide synthase 5 expression in microglia decreases neuroinflammation after spinal cord injury","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"24901","DOI":"10.1074\/jbc.M100314200","article-title":"Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells","volume":"276","author":"Ogretmen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s11033-024-09838-2","article-title":"The role of ceranib-2 and its nanoform on the decrease of telomerase levels in human non-small cell cancer","volume":"51","author":"Cengiz","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40995-021-01227-9","article-title":"A 5-fluorouracil derivative: Carmofur as a new potent agent for inhibition of human prostate and breast cancer cell lines","volume":"46","author":"Kutlu","year":"2022","journal-title":"Iran. J. Sci. Technol. Trans. A Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/17425255.2022.2138330","article-title":"Current status and new developments in sphingosine-1-phosphate receptor antagonism: Fingolimod and more","volume":"18","author":"Constantinescu","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"113278","DOI":"10.1016\/j.colsurfb.2023.113278","article-title":"Effective drug combinations of betulinic acid and ceranib-2 loaded Zn:MnO2 doped-polymeric nanocarriers against PC-3 prostate cancer cells","volume":"225","author":"Tan","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_22","first-page":"2322","article-title":"Proapoptotic effects of ceranib-2 in combination with radiation therapy on human breast cancer cells","volume":"28","author":"Kutlu","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41420-023-01738-x","article-title":"Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells","volume":"9","author":"Hawkins","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jare.2020.01.009","article-title":"Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells","volume":"23","author":"Larriva","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molmed.2011.03.002","article-title":"Translational aspects of sphingosine 1-phosphate biology","volume":"17","author":"Pyne","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/156652412803833599","article-title":"Molecular targets of FTY720 (fingolimod)","volume":"12","author":"Pitman","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11626-015-9932-9","article-title":"Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2","volume":"51","author":"Kus","year":"2015","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-811X-8-31","article-title":"PARP-1 cleavage fragments: Signatures of cell-death proteases in neurodegeneration","volume":"8","author":"Chaitanya","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103264","DOI":"10.1016\/j.msard.2021.103264","article-title":"Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis","volume":"56","author":"Correale","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ddr.21984","article-title":"Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacology","volume":"83","author":"Islam","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10616-017-0154-8","article-title":"The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non-small cell lung cancer cells in vitro","volume":"70","author":"Kus","year":"2018","journal-title":"Cytotechnology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-394274-6.00002-9","article-title":"Diverse functions of ceramide in cancer cell death and proliferation","volume":"117","author":"Saddoughi","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"key":"ref_38","first-page":"4301","article-title":"Exploiting cancer cell cycling for selective protection of normal cells","volume":"61","author":"Blagosklonny","year":"2001","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jat.3334","article-title":"Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening","volume":"37","author":"Tong","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s10616-016-9997-7","article-title":"Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells","volume":"68","author":"Vejselova","year":"2016","journal-title":"Cytotechnology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Asare, G.A., Anang, Y., Afriyie, D.K., Amoah, B.Y., Asiedu, B., Doku, D., Ocansey, H.S., Danso, N.Y.O., Tekpor, P., and Osam, S. (2017). Endogenous sphingolipid signaling pathway implicated in the action of Croton membranaceus on the prostate gland in BPH patients. Medicines, 4.","DOI":"10.3390\/medicines4040084"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:15:18Z","timestamp":1789388118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":41,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188126"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188126","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}